LERNER; Lorena
Patent Applications and Registrations
Patent applications and USPTO patent grants for LERNER; Lorena.The latest application filed is for "encapsulated rna polynucleotides and methods of use".
- LERNER; Lorena - Cambridge MA
- Lerner; Lorena - Newton MA
- Lerner; Lorena - Newton Centre MA
- Lerner; Lorena - Newton Center MA
| Patent | Date |
|---|---|
| Encapsulated Rna Polynucleotides And Methods Of Use App 20220117902 - LERNER; Lorena ; et al. | 2022-04-21 |
| Encapsulated Polynucleotides And Methods Of Use App 20210403950 - FINER; Mitchell H. ; et al. | 2021-12-30 |
| Rgmc-selective Inhibitors And Use Thereof App 20210380669 - Nicholls; Samantha ; et al. | 2021-12-09 |
| Anti-gdf-15 Antibodies App 20210101968 - Lerner; Lorena ; et al. | 2021-04-08 |
| Encapsulated Polynucleotides And Methods Of Use App 20200224220 - FINER; Mitchell H. ; et al. | 2020-07-16 |
| Oncolytic Viral Vectors And Uses Thereof App 20200206285 - FINER; Mitchell H. ; et al. | 2020-07-02 |
| Anti-GDF15 antibodies Grant 10,597,444 - Lerner , et al. | 2020-03-24 |
| Treatment Of Congestive Heart Failure And Other Cardiac Dysfunction Using A Gdf15 Modulator App 20190292251 - Gyuris; Jeno ; et al. | 2019-09-26 |
| Treatment Of Chronic Kidney Disease And Other Renal Dysfunction Using A Gdf15 Modulator App 20190292252 - Gyuris; Jeno ; et al. | 2019-09-26 |
| Methods Of Reversing Cachexia And Prolonging Survival Comprising Administering A Gdf15 Modulator And An Anti-cancer Agent App 20190292253 - Gyuris; Jeno ; et al. | 2019-09-26 |
| Anti-gdf15 Antibodies App 20180142013 - Lerner; Lorena ; et al. | 2018-05-24 |
| Methods Of Reversing Cachexia And Prolonging Survival Comprising Administering A Gdf15 Modulator And An Anti-cancer Agent App 20170306008 - Gyuris; Jeno ; et al. | 2017-10-26 |
| Methods of treatment using anti-GDF15 antibodies Grant 9,725,505 - Lerner , et al. August 8, 2 | 2017-08-08 |
| Treatment Of Congestive Heart Failure And Other Cardiac Dysfunction Using A Gdf15 Modulator App 20170137505 - Gyuris; Jeno ; et al. | 2017-05-18 |
| Treatment Of Chronic Kidney Disease And Other Renal Dysfunction Using A Gdf15 Modulator App 20170137506 - Gyuris; Jeno ; et al. | 2017-05-18 |
| Anti-gdf15 Antibodies App 20160083465 - Lerner; Lorena ; et al. | 2016-03-24 |
| Anti-GDF15 antibodies Grant 9,175,076 - Lerner , et al. November 3, 2 | 2015-11-03 |
| Anti-ron antibodies Grant 8,829,164 - Whalen , et al. September 9, 2 | 2014-09-09 |
| Anti-gdf15 Antibodies App 20140193427 - Lerner; Lorena ; et al. | 2014-07-10 |
| Anti-ron Antibodies App 20140066603 - Whalen; Kerry ; et al. | 2014-03-06 |
| Anti-RON antibodies Grant 8,603,478 - Whalen , et al. December 10, 2 | 2013-12-10 |
| Anti-ron Antibodies App 20120027773 - Whalen; Kerry ; et al. | 2012-02-02 |
| Directed complementation Grant 7,556,796 - Robinson , et al. July 7, 2 | 2009-07-07 |
| Directed complementation App 20060228302 - Robinson; Murray ; et al. | 2006-10-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 